Results 31 to 40 of about 48,845 (222)
Osteonecrosis of the jaws produced by sunitinib : a systematic review [PDF]
Tyrosine kinase receptor family is involved in tumor growth, pathological angiogenesis and the progression (metastasis) of cancer. Sunitinib (Sutent®) inhibits members of the tyrosine kinase receptor family affecting the induction of angiogenesis and ...
Ramírez, L. +15 more
core +1 more source
Although sunitinib contributes to prolonging the progression-free survival of metastatic renal cell carcinoma significantly, the universal presence of resistance limits the initial response rate and restricts durable responses. The mechanisms involved in
Liping Shan, Wei Liu, Yunhong Zhan
doaj +1 more source
Autophagy inhibition improves sunitinib efficacy in pancreatic neuroendocrine tumors via a lysosome-dependent mechanism. [PDF]
Increasing the efficacy of approved systemic treatments in metastasized pancreatic neuroendocrine tumors (PanNETs) is an unmet medical need. The anti-angiogenic tyrosine kinase inhibitor sunitinib is approved for PanNET treatment. Additionally, sunitinib
Normand, Lea Elena Haaning +26 more
core +2 more sources
Brain metastases from renal cell carcinoma are associated with poor prognosis. Sunitinib is a multi-targeted tyrosine kinase inhibitor used for the treatment of metastatic renal cell carcinoma.
Mali Amirault +6 more
doaj +1 more source
Sunitinib is a tyrosine kinase inhibitor that is frequently used in the treatment of metastatic renal cell carcinoma (mRCC). As a multikinase inhibitor, numerous off-target side effects of this medication are widely recognized.
David Song (13393110) +3 more
core
Representative pictures of the effect of sunitinib treatments on the HepG2 (with giant lysosomes) and SNU475 cell lines (with normal lysosomes). The rows show the treatment conditions: 1) Sunitinib 12 µM alone for 12 hours; 2) One hour of pre-incubation ...
Paola Cetrangolo (672519) +9 more
core +1 more source
Sunitinib-induced asthenia: from molecular basis to clinical relief [PDF]
[Abstract] Asthenia-fatigue syndrome (AFS) is defined as a persistent, subjective sense of tiredness related to cancer or its treatment and greatly impacts quality of life among cancer patients.
Aparicio Gallego, Guadalupe +6 more
core +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
AIM: Sunitinib has shown benefit in patients with imatinib (IM)–resistant gastrointestinal stromal tumor (GIST). However, its advantages are somewhat diminished because of associated toxicities.
Yen-Yang Chen +8 more
doaj +1 more source
A multi‐stage screening platform integrating human intestinal organoids with an intestinal microphysiological system enables evaluation of both inflammatory responses and mucosal architecture in inflammatory bowel disease. The platform distinguishes compounds that suppress inflammation from those that also preserve mucosal architecture, providing a ...
Fuki Yokoi +8 more
wiley +1 more source

